Filling the need for trusted information on national health issues
Mental health and substance use disorders are key public health issues and have received increased national attention in recent years. In light of the COVID-19 pandemic, a growing share of people report poor mental health and deaths due to drug overdose have reached record highs. Alongside these worsening issues, challenges with accessing mental health and substance use services have persisted. Poor mental health and barriers to care can vary geographically and by population characteristics. This page highlights relevant findings on the mental health landscape, including state-level data and analyses at the demographic level.
This brief discusses federal mental health parity protections — what they are, who they apply to, who enforces them and key policy issues as Congress and federal agencies evaluate improvements to the law to address gaps in mental health coverage and access.
The recent mass shootings in Uvalde and Buffalo have catalyzed discussion around mental health and gun policy. In the same week that the federal Bipartisan Safer Communities Act was signed strengthening background checks for young adults, adding incentives for red flag laws, and reducing access to guns for individuals with a domestic violence history, the Supreme Court struck down New York’s “proper cause” requirement for concealed carry allowances. In this issue brief, we use the Center for Disease Control and Prevention (CDC) Wonder database and the State Firearm Law Database to examine the association between suicide deaths by firearm and the number of state-level firearm law provisions.
In this issue brief, we use 2020 data from the National Survey on Drug Use and Health (NSDUH) to examine key characteristics, coverage and health status of nonelderly adults with mental illness or substance use disorders to help inform ongoing federal and state efforts to improve quality and expand access.
These FAQs review mental health and substance use disorder coverage and out-of-pocket costs in Medicare and discuss policy proposals related to coverage of mental health and substance use disorder treatments.
This post explains what’s known about how insurers use prior authorization as a tool to control costs and encourage cost-effective care, the state and federal laws that govern it, and ongoing policy debates over efforts to impose standards to limit or regulate its use.
Increased social isolation, stress, and unemployment as a result of the COVID-19 pandemic have contributed to a rise in mental health issues and substance use disorders (SUD) in the U.S. The impact of the pandemic has been particularly concerning for kids, as KFF’s most recent COVID Vaccine Monitor reported…
A new KFF COVID-19 Vaccine Monitor finds as many restrictions are being lifted, most of the public say they have personally returned to doing some of their pre-pandemic activities, but not all. In addition, majorities still report wearing masks in public indoor areas, but the public is split on whether the transportation mask mandate should continue. The pandemic has had a heavy toll on mental health, both for adults and their children, with people citing lack of human interaction and financial struggles as challenges over the last two years.
This analysis finds that before the pandemic, millions of adults reporting moderate to severe symptoms of anxiety and/or depression were not receiving treatment. Receipt of mental health treatment was lowest among young adults, Black adults, men, and uninsured people.
As California ramps up its CalAIM initiative, the state will incorporate and transition its Whole Person Care pilot program’s services statewide through the state’s Medicaid managed care system. This brief examines the lessons from those pilots in coordinating and integrating physical health, behavioral health, and social services.
The COVID-19 pandemic has coincided with worsening mental health across the country, and California is no exception. This data note find that in California in 2020, many nonelderly adults experienced poor mental health and did not receive needed care.
A new analysis from KFF and Epic Research finds that telehealth visits for outpatient mental health and substance use services went from virtually zero percent in 2019 prior to the COVID-19 pandemic to a peak of 40% in mid-2020 – and continued to account for more than a third (36%)…
This analysis from KFF and Epic Research finds that telehealth visits for outpatient mental health and substance use services went from virtually zero percent in 2019 prior to the COVID-19 pandemic to a peak of 40% in mid-2020 – and continued to account for more than a third of such visits in the six months ending in August 2021.
